title: Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients.
authors.affiliation: Clinical Research Institute for Endocrine Metabolic Disease, Kyoto Medical Center, Japan.
authors.forename: Noriko
authors.initials: N
authors.lastname: Satoh
authors.forename: Mitsuhide
authors.initials: M
authors.lastname: Naruse
authors.forename: Takeshi
authors.initials: T
authors.lastname: Usui
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Tagami
authors.forename: Takayoshi
authors.initials: T
authors.lastname: Suganami
authors.forename: Kazunori
authors.initials: K
authors.lastname: Yamada
authors.forename: Hideshi
authors.initials: H
authors.lastname: Kuzuya
authors.forename: Akira
authors.initials: A
authors.lastname: Shimatsu
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Ogawa
mesh_terms: D052242:Adiponectin; D000367:Age Factors; D001161:Arteriosclerosis / Q000209:etiology* / Q000517:prevention & control; D015415:Biomarkers / Q000032:analysis; D001823:Body Composition; D015992:Body Mass Index; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis*; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000032:analysis / Q000378:metabolism*; D020738:Leptin / Q000032:analysis / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000175:diagnosis*; D011336:Probability; D011379:Prognosis; D011446:Prospective Studies; D012016:Reference Values; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D012737:Sex Factors
chemical_list: D052242:Adiponectin; D015415:Biomarkers; D036341:Intercellular Signaling Peptides and Proteins; D020738:Leptin